INTERNAL DRUG DISCOVERY
AND DEVELOPMENT PIPELINE
Target
Target X
PHD2
QPCTL
MAT2A
3CL M
KAT6A
DGKA
PRO
Insilico Medicine's PHARMA.AI revolutionizes
Drug Discovery and Development
Innovative and accelerated internal drug candidate pipeline
Mechanism
indication
Stage of development
EMT, FMT,
fibroplast proliferation,
macrophage activation
EPO induction, iron utilization, epithelial integrity
Immune modulation
Synthetic lethality
Synthetic lethality
Virus replication
Epigenetics
Immune modulation
Idiopathic Pulmonary Fibrosis
Kidney Fibrosis
Skin Fibrosis
Immuno-Oncology
BRCA-mutant cancer
MTAP-/- cancer
COVID-19
ER+Breast cancer, AML
Solid tumors
Inflammatory Bowel Disease
Anemia of Chronic Kidney Disease
Discovery
IND-enabling
Phase 1
Others
Oncology
Immunology
Fibrosis
CDK12
Tumor cell proliferation
Solid tumors
ENPP1
Immune modulation
Solid tumors
USP1
Phase 2
Co-development with Fosun